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Abstract
Background Carcinomaofthegastricremnantafterpartial
gastrectomy for benign disease or cancer is unusual but an
important cancer model. The Japanese Society for the Study
of Postoperative Morbidity after Gastrectomy (JSSPMG)
performed a nationwide questionnaire survey to understand
the current state of gastric stump carcinoma in Japan.
Methods In the questionnaire survey of November 2008,
gastric stump carcinoma was deﬁned as an adenocarcinoma
of the stomach occurring 10 years or more after Billroth I
or Billroth II gastrectomy for benign condition or cancer
disease. The survey was conducted at the request of reports
on ﬁve or more patients with gastric stump carcinoma for
each institution. Items for the survey included gender, age,
methods of reconstruction in an original gastrectomy, ori-
ginal diseases, time interval between original gastrectomy
and ﬁrst detection of stump carcinomas, locations of stump
carcinomas, tumor histology, tumor depth, and extent of
lymph node metastasis. The questionnaire was sent to 163
surgical institutions in the JSSPMG.
Results Ninety-ﬁve institutions (58.3%) responded to the
survey, and the data of 887 patients satisﬁed the required
conditions for the survey. A total of 887 patients were
composed of 368 patients who received Billroth I distal
gastrectomyand519whoreceivedBillrothII.TheBillrothII
group has a signiﬁcantly higher number of original benign
lesions than the Billroth I group (P\0.001). This study
conﬁrmed the following issues: (1) The remnant stomach
after gastrectomy for cancer disease had a higher prevalence
to develop stump carcinomas occurring in a shorter time
intervalsinceoriginalgastrectomy;(2)PatientswithBillroth
II gastrectomy had stump carcinomas most frequently in the
anastomoticarea,butnotinthenon-stumpareaasinBillroth
I gastrectomy; (3) Tumor histology of 72.4% of 304 stump
carcinomas at an early stage was intestinal type adenocar-
cinoma, i.e., well or moderately differentiated adenocarci-
noma,whereasitdecreasedto42.2%atthelocallyadvanced
stage of 521 stump carcinomas (P = 0.0015), suggesting
that stump carcinoma mostly may develop from intestinal
type and change to diffuse type during the evolution to
advanced stage cancers.
Conclusions This large series of surveys suggest that
there are two distinct biological plausibilities in the
development of gastric stump carcinoma: (1) it develops in
a shorter time interval of 10 years or less since the original
gastrectomy, may come from a higher risk of gastric
mucosa after gastrectomy for cancer diseases that highly
predisposes to cancer, and (2) it develops during a longer
time interval of 20 years or more, may come from gas-
trectomy-relating mechanisms after gastrectomy for origi-
nal benign diseases.
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Carcinoma of the gastric remnant after partial gastrectomy
for benign disease or cancer is unusual but an important
cancer model. For the past 80 years, investigators have
suggested that there is an increased risk of gastric cancer
after gastrectomy for benign diseases [1–3]. Also, eleva-
tions in stomach cancer risk in the remnant stomach after
gastric surgery have been reported in several cohort stud-
ies [4–7]. However, other investigators have found no
increases in risk or increases limited to 15 or more years
after gastrectomy [8–10]. Several reports have postulated
that such different conclusions may come from some dis-
crepancies between studies, i.e., a study of gastric ulcer
patients alone would show an excess risk of gastric cancer,
irrespective of the follow-up periods, whereas one of the
duodenal ulcer patients alone would not indicate an excess
risk unless the follow-up was more than 20 years [10]. The
biological plausibility of the association of the remnant
stomach with cancer development stems from the previous
demonstration in animal models and in humans of increa-
ses in luminal bacterial ﬂora resulting from neutralization
of gastric acidity following gastric surgery [11, 12]. These
anaerobic bacteria convert nitrates consumed in the diet to
nitrites, known precursors of carcinogenic N-nitroso com-
pounds. In addition, persistent reﬂux of secondary bile, a
common result of gastric surgery, promotes chronic gas-
tritis and eventual metaplasia, often suggested as a pre-
cursor of neoplasia [13, 14].
Previous studies have demonstrated that rates of gastric
stump carcinoma are consistently higher after treatment
with a Billroth II procedure than after treatment with a
Billroth I procedure [6, 7, 10, 15–17]. The increased risk
with the Billroth II procedure has been attributed to con-
tinuous bathing of the gastric stump anastomosis with
secondary bile acids, resulting in mucosal inﬂammation
and regeneration [18].
In November 2008, the Japanese Society for the Study
of Postoperative Morbidity after Gastrectomy (JSSPMG)
conducted a nationwide questionnaire survey to evaluate
the current state of gastric stump carcinoma in Japan. This
paper demonstrates the results of 887 patients with gastric
stump carcinoma who underwent surgical treatment in 95
Japanese medical institutions that responded to the ques-
tionnaire survey of SSPMG.
Patients and methods
Gastric stump carcinoma is deﬁned as an adenocarci-
noma of the stomach occurring 10 years or more after
gastrectomy for benign disease or cancer. A minimal
latency of 10 years is chosen to avoid spurious effects
due to faulty diagnosis of conditions and to exclude any
cases with recurrent cancer diseases, because recurrent
cancer developing in the remnant stomach at 10 years or
more after original gastrectomy for cancer is extremely
rare [19, 20]. The methods for reconstruction after distal
gastrectomy in this survey were limited to the Billroth I
or Billroth II method and did not include any other type
of reconstruction, such as Roux-en-Y or jejunal inter-
position. Items for the questionnaire survey included
gender, age, methods of reconstruction at original gas-
trectomy, original disease, time interval between original
gastrectomy and the ﬁrst detection of stump carcinoma,
location of stump carcinoma, tumor histology, tumor
depth, and extent of lymph node metastases. The ques-
tionnaire was sent to a total of 163 surgical institutions
in the JSSPMG. The survey was conducted at the request
of reports on ﬁve or more patients with gastric stump
carcinoma for each institution.
Statistical analysis
Statistical analysis of the data was performed by SSPS
12.0 (SPSS, Chicago, IL, USA). All data are presented as
mean ± standard deviation (SD) or number and percentage
of patients. Continual variables, including time interval
after original surgery, have been expressed as mean ± SD,
and comparisons between groups were performed by using
the Mann–Whitney U test and t test. Comparisons of cat-
egorical variables were performed by using the Pearson’s
chi-square or Fisher exact tests. P\0.05 was considered
signiﬁcant.
Results
Ninety-ﬁve institutions (58.3%) responded to the survey,
and the data of 887 patients satisﬁed the required condi-
tions for the survey.
Time interval for development of stump carcinoma
and relevance of original diseases and modes
of reconstruction
A total of 887 patients were composed of 368 patients who
received Billroth I distal gastrectomy and 519 who
received Billroth II. More than 80% of patients of each
group were men. The mean ages and gender distribution of
both groups at detection of stump carcinoma were similar.
The Billroth II group has a signiﬁcantly higher number of
original benign lesions than the Billroth I group (P\
0.001). The time interval between original gastrectomy and
detection of stump carcinomas was 21.1 ± 9.5 years for
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11 years for 519 patients with Billroth II gastrectomy
(Table 1).
To elucidate the effect of the time interval since original
gastrectomy, the reported number of stump carcinomas was
examined over time after the original gastrectomy. A total
of 309 patients with original cancer disease (207 with the
Billroth II method and 102 with Billroth I) developed
stump carcinoma an average of 18.0 years after original
gastrectomy, whereas the average time interval was
extended to 32.0 years in 578 patients with original benign
disease (161 with Billroth I and 417 with Billroth II;
P\0.001). When they were separately analyzed with a
combination of Billroth methods, it was 27.2 ± 9 years for
161 patients with the Billroth I method and 33.9 ±
10.1 years for 417 patients with original benign disease
with the Billroth II method, whereas it was 16.4 ±
6.8 years for 207 patients with Billroth I and 21.3 ±
8.1 years for 102 patients with Billroth II in those with
original cancer disease (P[0.05; Table 2). Namely, the
patients with original cancer disease developed stump
carcinoma in a signiﬁcantly shorter time interval than those
with original benign diseases, but there was no signiﬁcant
difference in the time interval between Billroth I and
Billroth II for original benign or cancer disease.
The time trend of a reported number of stump carcino-
mas for every 5 years after original distal gastrectomy was
studied based on original benign or cancer diseases. For
patients with original cancer disease, the reported number
of stump carcinomas was the highest at 10–15 years after
surgery, followed by a gradual decrease in incidence
(Fig. 1). In contrast, for patients with original benign dis-
ease, it was the lowest incidence at 10–15 years after
surgery, followed by a steady increase (P\0.001; Fig. 1).
Tumor sites in the remnant stomach
The location of stump carcinomas was evaluated based on
the modes of reconstruction at original gastrectomy and the
original character of the disease. Tumor locations were
deﬁned as the following four parts, including the gastro-
duodenal or gastrojejunal anastomotic site, gastric stump
line, non-stump area, and broadly extended area in the
remnant stomach (Fig. 2). Of interest was that patients with
Billroth II gastrectomy had stump carcinomas most fre-
quently in the anastomotic area, regardless of the character
of the original diseases, whereas stump carcinomas for
those with Billroth I gastrectomy were more frequently
located in the non-stump area (Table 3).
Tumor histology
Distribution of tumor histology of the stump carcinoma
was evaluated based on tumor stages and tumor sites.
Tumor histology of 72.4% of 304 stump carcinomas at an
early stage was intestinal type adenocarcinoma, i.e., well or
moderately differentiated adenocarcinoma, whereas it
decreased to 42.2% at the locally advanced stage of 521
stump carcinomas (P = 0.0015). This trend was consistent
irrespective of the tumor sites (data not shown).
Tumor depth and extent of lymph node metastasis
of stump carcinomas
Distribution of tumor depth and extent of lymph node
metastasis also were evaluated based on the modes of
reconstruction at original gastrectomy and characteristics
of the original disease (Fig. 3a, b). Earlier stage of stump
carcinomas, such as a tumor conﬁned in the mucosa or
submucosa (T1) and no lymph node metastasis (no), were
more frequently detected in patients with Billroth I gas-
trectomy than those with Billroth II gastrectomy, regardless
of the characteristics of the original disease (P\0.0001
for T1 stage, P = 0.0102 for no stage).
Surgical procedures for stump carcinomas
Modes of surgical procedure for stump carcinomas were
evaluated in a similar way. Most surgical procedures
Table 1 Comparison of baseline characteristics in the groups with
Billroth I or Billroth II reconstruction
Billroth I Billroth II
No. of patients 368 519
Male:female (%) 82:18 88:12
Age (yr) 68 ± 9.4 68 ± 9.2
Benign:cancer in origin 161:207 417:102
Intestinal:diffuse 190:178 261:258
Early:advanced 154:214 163:256
Time interval (year) 21.1 ± 9.5 31.5 ± 11.0
Age and time intervals are mean ± standard deviation
Table 2 Comparison of baseline characteristics in the groups strati-
ﬁed by combination of Billroth I or II reconstruction and original
diseases
Mode of surgery BI benign BI cancer BII benign BII cancer
No. of patients 161 207 417 102
Male:female (%) 86:14 79:21 91:9 76:4
Age (year) 67 ± 9.4 69 ± 9.3 67 ± 9.2 70 ± 8.4
Time interval
(year)
27.2 ± 9.0 16.4 ± 6.8 33.9 ± 10.1 21.3 ± 8.1
BI benign Billroth I reconstruction for an original benign disease, BI
cancer Billroth I reconstruction for an original cancer disease
Age and time intervals are mean ± standard deviation
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Billroth I or II original gastrectomy. Partial gastrectomy and
local resection, including endoscopic mucosal resection
(EMR) or endoscopic submucosal dissection (ESD), were
signiﬁcantly more frequent in patients with original benign
disease than those with original cancer disease (Fig. 4;
P = 0.0105).
Discussion
Although a questionnaire survey is a useful tool for
answering clinical inquiries by pooling data, it has the
following drawbacks. The results of the survey are inﬂu-
enced by the character of the questions, including contents,
order, length and the method of description, and the survey
study lacks any systems of objective validation of the
reported data. In addition, this case-survey study cannot
estimate the incidence rate of the disease because the study
does not include all patients like in a cohort setting. Despite
these limitations, the present questionnaire survey makes
important observations in the understanding of gastric
stump carcinoma in Japan.
This study conﬁrmed some important matters,
including the fact that patients with original cancer dis-
ease developed stump carcinoma in a signiﬁcantly
shorter time interval than those with original benign
diseases, mostly peptic ulcers. The time trend of the
reported number of stump carcinomas was quite different
in manner between the patients with original cancer
diseases and those with benign conditions. Namely, it
was the highest at 10–15 years (shortest time interval in
the study) followed by a gradual decrease in number
thereafter for patients with original cancer diseases,
whereas it was the lowest at 10–15 years after surgery
for patients with original benign diseases, followed by a
steady increase thereafter.
100
50
0
10-15Y 16-20Y    21-25Y          26-30Y 31-35Y    36- 40Y 41Y-45Y  46Y-
Benign
Cancer
Fig. 1 Time trend of a reported
number of stump carcinomas
every 5 years after original
distal gastrectomy for benign
or cancer diseases: after
gastrectomy for benign
diseases; after gastrectomy
for cancer
Fig. 2 Tumor locations in the remnant stomach. a Anastomotic site;
b gastric stump line; c non-stump area
Table 3 Tumor locations of stump carcinomas in the remnant
stomach mode of surgery
Mode of surgery BI benign BI cancer BII benign BII cancer
No. of patients 161 (100) 207 (100) 417 (100) 102 (100)
Anastomotic site 42 (26) 39 (20) 250 (60) 39 (38)
Stump line 36 (22) 17 (23) 50 (12) 18 (17)
Non-stump area 73 (46) 103 (51) 83 (20) 31 (31)
Extended 10 (6) 13 (6) 34 (8) 14 (14)
BI benign Billroth I reconstruction for an original benign disease, BI
cancer Billroth I reconstruction for an original cancer disease
Data in parentheses are percentages
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161 (100* * *) 207(100) 417 (100) 102 (100) ᧤Number of patients᧥
T 1 ****
T 2
100
50
0
62
(39)
47
33
19
91
(44)
55
28 33
130
(31)
113
117
57
32
(31) 30
19 21
T 3
T 4
B - benign* B - cancer * * B - benig         B - cancer ᧤ ᧤Mode of Surgery᧥ 
161 (100* * *) 207 (100) 417 (100) 102 (100) ᧤Number of  patients ᧥
n 0 ****
n 1
200
100
0
99
(62)
25 26
7
141
(68)
35
12 13
232
(56)
69 74
30
62
(61)
9
22
5
n 2
n 3
M
4 6 12 4
A
B
Fig. 3 a Tumor depths of
stump carcinomas. * BI-benign
means Billroth I gastrectomy for
an original benign disease.
** BI-cancer means Billroth I
gastrectomy for an original
cancer disease. *** Number in
parenthesis is a percentage.
**** T1–4 was deﬁned
according to the UICC
classiﬁcation. b Extent of lymph
node metastases of stump
carcinomas. * BI-benign means
Billroth I gastrectomy for an
original benign disease. ** BI-
cancer means Billroth I
gastrectomy for an original
cancer disease. *** Number in
parenthesis is a percentage.
**** n0–3 and M were deﬁned
according to the UICC
classiﬁcation
B - benign B - cancer B - benig       B - cancer
161 (100 ) 207 (100) 417 (100) 102 (100)
Total gastrectomy
Partial gastrectomy
Local resection or
ESD/EMR
Non-resectable
(%)
100
0
136
(85)
14
5
188
(91)
6
2
3
14
46
352
(85)
8
11 5
4
2
91
(89) 136
(85)
188
(91)
352
(84)
91
(89)
* * *
* * *
Fig. 4 Surgical procedures
for gastric stump carcinomas.
* BI-benign means Billroth I
gastrectomy for an original
benign disease. ** BI-cancer
means Billroth I gastrectomy for
an original cancer disease.
*** Number in parenthesis is a
percentage. EMR endoscopic
mucosal resection, ESD
endoscopic submucosal
dissection
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123Those data seem to suggest that carcinogenesis in the
remnant stomach may occur based on quite different
mechanisms, namely one may come from mucosa with
higher risk in the remnant stomach after gastrectomy for
cancer diseases and another may come from some already
reported mechanisms developed after gastrectomy for ori-
ginal benign diseases [13, 14, 18]. Regarding the risk of
stump carcinoma after gastric surgery for benign diseases,
several investigations in western countries have reported
on possible elevations in gastric stump carcinoma risk after
gastric surgery [10, 21, 22], although other studies have
found no increases in risk or increases limited to 15 or
more years after gastrectomy for benign diseases [4, 5, 8, 9,
16, 23]. Thus, it is controversial whether the development
of gastric stump carcinoma may be directly related to the
postoperative time interval. However, part of this study of
postgastrectomy for benign diseases conﬁrmed that there is
a higher risk of development of stump carcinoma in post-
operative stomach and the risk increases gradually over
time until 30 years postoperatively. In addition, although
some studies [16, 24] suggested that the risk of gastric
stump carcinomas increases after an apparent latency of
20 years or more after gastric surgery, there was no latency
period found in the current study. The issue of whether
there would be different risk of stump carcinoma based on
the mode of reconstruction, Billroth I or II, is of interest.
However, when the association between risk of stump
carcinoma and the mode of reconstruction is evaluated, we
should consider the varying number of applications of
Billroth I or II procedures in these decades, because indi-
cation and absolute number of Billroth I or II procedures
were not constant during these periods. It was preferable to
use the Billroth II procedure, but not Billroth I, for gas-
trectomy for peptic ulcers before the late 1980 s in Japan
[25]. Since H2-blocker became available for use in our
clinics from the late 1980s to the early 1990s, the number
of gastric surgeries for peptic ulcers remarkably decreased
since 1990 in Japan [26, 27], and at the same time Billroth I
gastrectomy, instead of Billroth II gastrectomy, has become
the standard procedure for cases with peptic ulcer diseases
[25, 27]. As this questionnaire survey was performed in the
fall of 2008, the Billroth I procedure for peptic ulcers
seemed to be more frequently applied than the Billroth II
procedure at 16–20 or less postoperative years, whereas the
number of Billroth II procedures was more dominant at
21–25 or more postoperative years. In addition to such
variable backgrounds, as Table 2 indicates, there was no
signiﬁcant difference in the time interval between Billroth I
and Billroth II gastrectomy for original benign or cancer
disease. Accordingly, this retrospective survey does not
seem appropriate to study the association of risk of stump
carcinoma development with the mode of reconstruction.
Tumor locations in the remnant stomach were charac-
teristic. Consistent with previous reports [12, 28–30],
patients with Billroth II gastrectomy had stump carcinomas
most frequently in the anastomotic area, but not the non-
stump area, such as those with Billroth I gastrectomy. This
issue is in line with various reports, indicating that the
increased risk with the Billroth II procedure has been
attributed to continuous bathing of the gastric stump
anastomosis with secondary bile acids, resulting in mucosal
inﬂammation and regeneration [18].
Evolutional changes of tumor histology of gastric stump
carcinomas between an early stage and a locally advanced
stage also were of interest, suggesting the stump carcinoma
may mostly develop from intestinal type adenocarcinoma
and change to diffuse type, during evolution towards locally
advanced cancers. Gastritis cystic polyposa has long been
identiﬁedasacharacteristicprecursorlesionofgastricstump
carcinoma [31]. The issue that most of the early stump car-
cinomas were of the intestinal type in the current analysis
does not conﬂict with previous ﬁndings. As for tumor his-
tology of primary gastric cancer, there are, in general,
slightly more intestinal types (55–60%) with early cancers
and more diffuse types (58–63%) with advanced cancers
[32–34]. Therefore, obvious changes of tumor histology in
the current study may indicate a typical pattern of clonal
evolution during the progression of gastric cancer.
The analysis of distribution of tumor depth and extent of
lymph node metastases demonstrated that earlier stage
stump carcinomas were found more in patients with Bill-
roth I gastrectomy, probably because of easier detection of
stump carcinoma in patients with Billroth I gastrectomy
and less frequency of clinical manifestations in those with
Billroth II [35].
Regarding surgical procedures for stump carcinomas,
signiﬁcantly more frequent application of partial gastrec-
tomy and local resection for patients with those benign in
origin might be associated with a rather larger size of
stomach remaining for those patients.
The prevalence of Helicobacter pylori infection, a
recently reported risk factor for stomach cancer [36, 37]i s
not known in this study sample. However, the current study
clearly indicates that the remnant stomach after gastrec-
tomy for cancer had higher prevalence to develop stump
carcinomas occurring in a shorter time interval, suggesting
a relationship between the higher risk of gastric mucosa
and development of stump carcinomas in a shorter time
interval. It is now widely accepted that Helicobacter pylori
plays a role in the pathogenesis of gastric cancer. In
addition, the higher prevalence of Helicobacter pylori
infection in early cancer than in locally advanced cancer
may suggest its possible association with the pathogenesis
of gastric stump carcinomas [38].
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This study provides adequate power to detect important
observations in the understanding of gastric stump carci-
noma by virtue of the large sample (887 patients with
gastric stump carcinomas). This study conﬁrms the fol-
lowing important issues: (1) Patients with original cancer
disease developed stump carcinoma in a signiﬁcantly
shorter time interval than those with original benign con-
ditions whose stump carcinomas gradually increased as
years passed; (2) Patients with Billroth II gastrectomy had
stump carcinomas most frequently in the anastomotic area
but not in the non-stump area like those with Billroth I
gastrectomy; (3) There were remarkable differences in the
tumor histology of gastric stump carcinomas between the
early stage mostly having intestinal type and the locally
advanced stage having diffuse type.
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Addendum
Institution (Principal Investigators)
National Cancer Center (Katai H), Kanazawa Medical
University (Takashima S), National Cancer Center Hospi-
tal East (Kinoshita T), Aichi Cancer Center (Yamamura
Y), Yokohama City University Medical Center (Kunisaki
T), Nippon Medical School (Tajiri T), Kyoto Second Red
Cross Hospital (Takenaka A), Kyoto Prefectural University
of Medicine (Otsuji E), National Kyushu Cancer Center
(Fuji Y), Juntendo University School of Medicine (Tsuru-
maru M), Tokyo Women’s Medical University Center East
(Ogawa K), Niigata City General Hospital (Saito H),
Kanazawa University Graduate School of Medical Science
(Ota T), Ibaraki Prefectural Central Hospital (Nagai H),
Osaka Koseinenkin Hospital (Yamazaki Y), Graduate
School of Medicine and Faculty of Medicine, the Univer-
sity of Tokyo (Kaminishi M), Hiroshima City Asa Hospital
(Takiyama W), Kitasato University East Hospital (Saku-
ramoto S), School of Medicine Hirosaki University (Sasaki
M), Osaka Medical College (Tanigawa N), Osaka City
University Graduate School of Medicine (Hirakawa K),
Toyonaka Municipal Hospital (Tsukahara Y), Niigata
University Graduate School of Medical and Dental Sci-
ences (Hatakeyama K), Miyagi Cancer Center (Fujiya T),
University of Yamanashi Hospital (Fujii H), Health
Insurance Naruto Hospital (Iwasaka N), Saku Central
Hospital, Nagano Prefectural Federation of Agricultural
Cooperatives for Health and Welfare (Ooi E), Tsuruoka
municipal Shonai Hospital (Matsubara Y), Fukui Red
Cross Hospital (Matsushita T), Hoshigaoka Koseinenkin
Hospital (Tatsumi M), Akita University Graduate School
of Medicine (Yamamoto Y), Arita GI Hospital (Arita T),
Iwate Medical University (Wakabayashi G), Chiba Cancer
Center (Takiguchi N), Yonezawa City Hospital (Kitamura
M), University of Occupational and Environmental Health
(Nagata N), Yamagata Prefectural Kahoku Hospital
(Watanabe S), Yamagata University Faculty of Medicine
(Kimura W), Social Insurance Chuo General Hospital
(Bandai Y), Asahikawa Medical College (Kasai S), Asa-
hikawa Red Cross Hospital (Hishiyama T), Ishikawa Pre-
fectural Central Hospital (Yamada T), Oita University
Faculty of Medicine Graduate School of Medicine (Kitano
S), Osaka University Graduate School of Medicine, Faculty
of Medicine (Monden M), Okayama Saiseikai Gen-
eral Hospital (Takabatake T), Kanagawa Cancer Center
(Yoshikawa T), Kyushu University (Maehara Y), Gifu
Municipal Hospital (Oshita H), Niigata Cancer Center
Hospital (Nashimoto A), Tohoku University Hospital
(Sasaki I), Saitama Medical Center (Ishida H), Sasebo City
General Hospital (Ishikawa H), Shiga University of Med-
ical Science (Tani T), Shikoku Cancer Center (Kurita H),
Showa University of Toyosu Hospital (Kumagai K), Showa
University Hospital (Kusano M), Sakai Municipal Hospital
(Furukawa H), Saitama Medical Center Jichi Medical
University (Konishi F), Tokai University Tokyo Hospital
(Kondo Y), Kashiwa Hospital, Jikei University School of
Medicine (Nakada K), Tokyo Women’s Medical Univer-
sity Hospital (Yamamoto M), Tokyo Metropolitan Cancer
and Infectious diseases Center Komagome Hospital (Iwa-
saki Y), Tochigi Cancer Center (Inada T), Tokyo Metro-
politan Bokutoh Hospital (Arai K), Dokkyo Medical
University (Sunagawa M), Nagaoka Chuo General Hospital
(Shimizu T), Niigata Prefecture Yoshida Hospital (Tamiya
Y), Nippon Medical School Musashi Kosugi Hospital
(Tokunaga A), Nihon University School of Medicine
(Takayama T), Himeji Central Hospital (Ishida Y), Hiro-
shima City Hospital (Ninomiya M), Fukushima Medical
University (Goto M), Fujita Health University (Uyama I),
Hokkaido Cancer Center (Naito H), National Defense
Medical College (Mochizuki H), Matsuyama Shimin
Hospital (Miyata N), South Miyagi Medical Center (Naito
H), Yamaguchi University (Oka M), Wakayama Rosai
Hospital (Tsuji T), Osaka Medical Center for Cancer and
Cardiovascular Diseases (Miyashiro I), Tokyo Medical
University (Aoki T), Nagasaki University (Kanematsu T),
Hokkaido Gastroenterology Hospital (Morita T), Aizawa
Hospital (Tanaka K), NTT West Osaka Hospital (Monden
T), Public Shiso General Hospital (Yamasaki Y), Hokkaido
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123P.W.F.A.C Asahikawa-Kosei General Hospital (Takahashi
M), Nagoya City University (Fujii Y), Kinki University
School of Medicine (Shiozaki H), Teikyo University
School of Medicine University Hospital, Mizonokuchi
(Sugiyama Y).
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